Login to Your Account

Royalty Pharma Bids $6.6B for Elan, but Is It a Fair Offer?

By Cormac Sheridan
Staff Writer

Wednesday, February 27, 2013
DUBLIN, Ireland – Shares in Elan Corp. plc (NYSE:ELN) rose 5 percent to $11.14 Monday in response to an indicative $11 per-share takeover offer from Royalty Pharma.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription